Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifevantage (LFVN) Other financing activities (2017 - 2026)

Lifevantage filings provide 8 years of Other financing activities readings, the most recent being $12000.0 for Q3 2025.

  • On a quarterly basis, Other financing activities changed N/A to $12000.0 in Q3 2025 year-over-year; TTM through Dec 2025 was $12000.0, a 100.91% increase, with the full-year FY2024 number at $97000.0, changed N/A from a year prior.
  • Other financing activities hit $12000.0 in Q3 2025 for Lifevantage, down from $60000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $12000.0 in Q3 2025 to a low of $12000.0 in Q3 2025.